Staphylococcal Infection

• EMA approval · 2025-11-21
  EMA Authorised: Invanz (ertapenem sodium) — Merck Sharp & Dohme B.V.

  The European Medicines Agency authorised Invanz (ertapenem sodium) by Merck Sharp & Dohme B.V. for a range of infections including community…

• FDA approval · 2025-05-13
  FDA Approved: MUPIROCIN — Original Application (Encube Ethicals, Inc.)

  FDA approves Encube Ethicals, Inc.'s original application for mupirocin topical antibiotic (generic mupirocin).

• FDA approval · 2021-11-16
  FDA Approved: MUPIROCIN — Original Application (Alembic Pharmaceuticals Inc.)

  The FDA approved Alembic Pharmaceuticals' original ANDA for mupirocin topical ointment, authorizing its marketing as a generic antibiotic fo…

• FDA approval · 2016-01-05
  FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's supplemental application for a generic mupirocin product (ANDA 090480).

• FDA approval · 2015-11-18
  FDA Approved: MUPIROCIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA has approved a supplemental application for mupirocin from Sun Pharmaceutical Industries, Inc., signaling an approved change related to …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2013-01-24
  FDA Approved: MUPIROCIN — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's original ANDA for mupirocin topical antibiotic, enabling a generic version to be marketed. The approval confirms the…